Higher prices for MS drug help drug firm Merck
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.
May 14, 2013
0
0
(AP)—Higher prices for its multiple sclerosis drug Rebif helped German pharmaceutical and high-tech materials company Merck KGaA post a 54 percent rise in first-quarter profit.
May 14, 2013
0
0
Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.
Jul 27, 2012
0
0
French pharmaceutical group Sanofi reported a slump in profits for the third quarter of the year on Wednesday owing to the lagging effects of the ending of exclusive patent rights.
Oct 30, 2013
0
0
British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face ...
Apr 30, 2021
0
5
Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
May 1, 2013
0
0
British drugs firm GlaxoSmithKline on Wednesday said its first-quarter net profit tumbled by almost a third, with the group hit by falling sales and a poor economic climate.
Apr 24, 2013
0
0
India's second-largest drugmaker Dr Reddy's Laboratories on Tuesday reported a 69.4 percent jump in quarterly net profit, as profit margins rose helped by improved sales.
Oct 31, 2013
0
0
British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 21 percent in the first three months of the year thanks to strong growth in sales of cancer drugs.
Apr 25, 2024
0
0
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
British pharmaceuticals group AstraZeneca announced on Thursday a slump in quarterly profits, in part on higher investment costs, but raised its outlook for full-year revenues.
Nov 6, 2014
0
0